XML 47 R4.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)
In Thousands, except Per Share data, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Sep. 30, 2012
Sep. 30, 2011
Revenues:        
Product sales, net $ 16,176 $ 15,802 $ 44,304 $ 39,905
License fee and other collaboration revenues 1,566 1,707 19,911 6,322
Royalties   46 19 115
Total revenues 17,742 17,555 64,234 46,342
Costs and expenses:        
Cost of product sales 4,323 2,669 10,193 7,792
Research and development expenses 5,260 14,894 25,393 45,155
Selling, general and administrative expenses 12,160 17,230 40,442 53,690
Restructuring expenses 562   1,620  
Total costs and expenses 22,305 34,793 77,648 106,637
Other income (expense):        
Interest and dividend income, net 295 378 1,026 1,390
Gains (losses) on investments, net 2 14 (1,469) (194)
Total other income (expense) 297 392 (443) 1,196
Net loss before income taxes (4,266) (16,846) (13,857) (59,099)
Income tax benefit 299 215 793 611
Net loss $ (3,967) $ (16,631) $ (13,064) $ (58,488)
Net loss per share:        
Basic and diluted (in dollars per share) $ (0.19) $ (0.78) $ (0.61) $ (2.76)
Weighted average shares outstanding used to compute net loss per share:        
Basic and diluted (in shares) 21,403 21,194 21,374 21,169